Middletown, DE -- (SBWIRE) -- 10/02/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Associated Banc Corp (NASDAQ:ASBC), BioScrip Inc (NASDAQ:BIOS), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Pacific Biosciences of California (NASDAQ:PACB).
Associated Banc Corp (NASDAQ:ASBC), ended with a volume of 2.08 million shares versus the average volume of the stock 1.36 million shares. The stock grew1.68 % and ended at $15.75. The market capitalization of the stock remained 2.61 million. The beta of the stock was 0.56.
Will ASBC Continue To Move Higher? Find Out Here
The Company organizes its business into two segments: Banking and Wealth Management. Associated’s banking and wealth management activities are conducted in Wisconsin, Minnesota, and Illinois, and are primarily delivered through branch facilities in this tri-state area.
BioScrip Inc (NASDAQ:BIOS), traded 1.97 million shares in the last business day while the average volume of the stock remained 1.75 million shares. The 52 week range of the stock remained $8.29 - $17.62. The stock showed a negative movement of -1.25% to end at $8.67. The market capitalization of the stock remained 587.65 Million.
Will BIOS Get Buyers Even After The Recent Rally? Find Out Here
BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), its volume was 1.92 million shares as compared to the average volume of713,718 shares. The stock boosted6.60% in its last trading session and reached a price of $4.20.
Will ZIOP Continue To Move Higher? Find Out Here
ZIOPHARM Oncology, Inc. (ZIOPHARM) is a biopharmaceutical company that focuses on the discovery and development of new cancer therapies. ZIOPHARM is applying its technologies in cancer research to develop therapeutics for patients.
Pacific Biosciences of California (NASDAQ:PACB) showed a volume of 1.89 million shares by the end of last trade whereas the average volume of the stock remained 1.04 million shares. The 52 week range of the stock remained $1.06 - $6.50 and the day range was $5.47 - $5.95. The stock opened the session at $5.50 but then moved to $5.84. At that price, the stock showed a positive performance of 5.80%.
Will PACB Continue To Move Higher? Find Out Here
Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)